相关实验视频

Updated: Jun 11, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

556

探索针对PD-L1和STAT3的天然化合物:毒基因组分析,虚拟查,分子对接,ADMET评估和生物活动预测

Fuat Karakuş1, Burak Kuzu2, Sedat Köstekci3

  • 1Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Türkiye.

Current computer-aided drug design
|May 29, 2024
PubMed
概括

这项研究确定了6-Prenylapigenin作为一种潜在的非毒性天然化合物,可以抑制编程细胞死亡连接体1 (PD-L1) 和其主调节器,信号转换器和转录激活器3 (STAT3). 这一发现可能会导致新的小分子癌症免疫疗法.

关键词:
6 - 普林尼拉皮基尼尼.在PD-L1中.在STAT3中,我们可以使用STAT3.凝化物 J 凝化物自然化合物 自然化合物蛋白质. 蛋白质. 这是蛋白质.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

290

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...